CompletedNot Applicable

Evolution of the Quality of Life and Experience of Young Women With Utero-vaginal Aplasia (MRKHPSY)

France25 participantsStarted 2022-10-04

Plain-language summary

This study aims to evaluate the global evolution of the quality of life on patients diagnosed with MRKH syndrome (Mayer-Rokitansky-Kuster-Hauser), 8 to 10 years after the first research.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient aged of 18 years old or older * Patient who participated in the initial T1 psychological component of the previous study (MRKH protocol) Exclusion Criteria \- Refusal to participate in the study

What they're measuring

Evaluation of global quality of life

Timeframe: Day 0

Trial details

NCT IDNCT05415540

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-27

View on ClinicalTrials.gov More Mrkh Syndrome trials